vs

Side-by-side financial comparison of Cytosorbents Corp (CTSO) and Valaris Ltd (VAL). Click either name above to swap in a different company.

Cytosorbents Corp is the larger business by last-quarter revenue ($9.2M vs $5.2M, roughly 1.8× Valaris Ltd). Valaris Ltd runs the higher net margin — 13798.1% vs -59.5%, a 13857.6% gap on every dollar of revenue. On growth, Valaris Ltd posted the faster year-over-year revenue change (405.9% vs 0.9%). Cytosorbents Corp produced more free cash flow last quarter ($-4.9M vs $-34.1M). Over the past eight quarters, Valaris Ltd's revenue compounded faster (29.5% CAGR vs 1.3%).

CytoSorbents Corporation is a publicly traded company located in Princeton, New Jersey.

Valaris Limited is an offshore drilling contractor headquartered in Houston, Texas, and incorporated in Bermuda. It is the largest offshore drilling and well drilling company in the world. As of February 2025, it owned 52 rigs, including 36 offshore jackup rigs, 11 drillships, and 5 semi-submersible platform drilling rigs.

CTSO vs VAL — Head-to-Head

Bigger by revenue
CTSO
CTSO
1.8× larger
CTSO
$9.2M
$5.2M
VAL
Growing faster (revenue YoY)
VAL
VAL
+405.0% gap
VAL
405.9%
0.9%
CTSO
Higher net margin
VAL
VAL
13857.6% more per $
VAL
13798.1%
-59.5%
CTSO
More free cash flow
CTSO
CTSO
$29.2M more FCF
CTSO
$-4.9M
$-34.1M
VAL
Faster 2-yr revenue CAGR
VAL
VAL
Annualised
VAL
29.5%
1.3%
CTSO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CTSO
CTSO
VAL
VAL
Revenue
$9.2M
$5.2M
Net Profit
$-5.5M
$717.5M
Gross Margin
73.7%
-7850.0%
Operating Margin
-47.5%
Net Margin
-59.5%
13798.1%
Revenue YoY
0.9%
405.9%
Net Profit YoY
27.4%
436.6%
EPS (diluted)
$-0.09
$10.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTSO
CTSO
VAL
VAL
Q4 25
$9.2M
$5.2M
Q3 25
$9.5M
$5.6M
Q2 25
$9.6M
$700.0K
Q1 25
$8.7M
Q4 24
$9.2M
$-1.7M
Q3 24
$8.6M
$3.9M
Q2 24
$8.8M
$4.8M
Q1 24
$9.0M
$2.6M
Net Profit
CTSO
CTSO
VAL
VAL
Q4 25
$-5.5M
$717.5M
Q3 25
$-3.2M
$188.1M
Q2 25
$1.9M
$115.1M
Q1 25
$-1.5M
Q4 24
$-7.6M
$133.7M
Q3 24
$-2.8M
$64.6M
Q2 24
$-4.3M
$149.6M
Q1 24
$-6.1M
$25.5M
Gross Margin
CTSO
CTSO
VAL
VAL
Q4 25
73.7%
-7850.0%
Q3 25
70.3%
-7142.9%
Q2 25
70.9%
-56428.6%
Q1 25
71.1%
Q4 24
68.4%
24529.4%
Q3 24
61.0%
-11748.7%
Q2 24
73.5%
-9039.6%
Q1 24
76.5%
-17007.7%
Operating Margin
CTSO
CTSO
VAL
VAL
Q4 25
-47.5%
Q3 25
-30.2%
Q2 25
-37.6%
Q1 25
-44.5%
Q4 24
-37.1%
Q3 24
-56.1%
Q2 24
-40.4%
Q1 24
-51.8%
Net Margin
CTSO
CTSO
VAL
VAL
Q4 25
-59.5%
13798.1%
Q3 25
-33.4%
3358.9%
Q2 25
20.2%
16442.9%
Q1 25
-16.9%
Q4 24
-82.7%
-7864.7%
Q3 24
-32.1%
1656.4%
Q2 24
-48.6%
3116.7%
Q1 24
-67.7%
980.8%
EPS (diluted)
CTSO
CTSO
VAL
VAL
Q4 25
$-0.09
$10.13
Q3 25
$-0.05
$2.65
Q2 25
$0.03
$1.61
Q1 25
$-0.02
Q4 24
$-0.14
$1.86
Q3 24
$-0.05
$0.88
Q2 24
$-0.08
$2.03
Q1 24
$-0.11
$0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTSO
CTSO
VAL
VAL
Cash + ST InvestmentsLiquidity on hand
$6.2M
$599.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$5.9M
$3.2B
Total Assets
$44.2M
$5.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTSO
CTSO
VAL
VAL
Q4 25
$6.2M
$599.4M
Q3 25
$7.5M
$662.7M
Q2 25
$10.2M
$503.4M
Q1 25
$11.6M
Q4 24
$3.3M
$368.2M
Q3 24
$5.7M
$379.3M
Q2 24
$8.5M
$398.3M
Q1 24
$8.6M
$494.1M
Total Debt
CTSO
CTSO
VAL
VAL
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$13.8M
Q2 24
$13.7M
Q1 24
$4.4M
Stockholders' Equity
CTSO
CTSO
VAL
VAL
Q4 25
$5.9M
$3.2B
Q3 25
$9.0M
$2.4B
Q2 25
$11.6M
$2.3B
Q1 25
$14.5M
Q4 24
$11.1M
$2.2B
Q3 24
$13.4M
$2.1B
Q2 24
$17.4M
$2.2B
Q1 24
$19.6M
$2.0B
Total Assets
CTSO
CTSO
VAL
VAL
Q4 25
$44.2M
$5.3B
Q3 25
$45.8M
$4.6B
Q2 25
$48.0M
$4.5B
Q1 25
$50.8M
Q4 24
$47.4M
$4.4B
Q3 24
$47.8M
$4.3B
Q2 24
$53.4M
$4.4B
Q1 24
$47.1M
$4.4B
Debt / Equity
CTSO
CTSO
VAL
VAL
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
1.03×
Q2 24
0.78×
Q1 24
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTSO
CTSO
VAL
VAL
Operating Cash FlowLast quarter
$-4.8M
$72.2M
Free Cash FlowOCF − Capex
$-4.9M
$-34.1M
FCF MarginFCF / Revenue
-53.4%
-655.8%
Capex IntensityCapex / Revenue
1.2%
2044.2%
Cash ConversionOCF / Net Profit
0.10×
TTM Free Cash FlowTrailing 4 quarters
$-12.5M
$159.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTSO
CTSO
VAL
VAL
Q4 25
$-4.8M
$72.2M
Q3 25
$-2.6M
$198.1M
Q2 25
$-1.5M
$120.0M
Q1 25
$-3.5M
Q4 24
$-2.3M
$124.6M
Q3 24
$-2.5M
$193.0M
Q2 24
$-4.8M
$11.5M
Q1 24
$-4.8M
$26.3M
Free Cash Flow
CTSO
CTSO
VAL
VAL
Q4 25
$-4.9M
$-34.1M
Q3 25
$-2.6M
$128.3M
Q2 25
$-1.5M
$52.8M
Q1 25
$-3.5M
Q4 24
$-2.4M
$12.9M
Q3 24
$-2.6M
$111.1M
Q2 24
$-4.8M
$-98.7M
Q1 24
$-4.9M
$-125.0M
FCF Margin
CTSO
CTSO
VAL
VAL
Q4 25
-53.4%
-655.8%
Q3 25
-27.3%
2291.1%
Q2 25
-16.1%
7542.9%
Q1 25
-39.7%
Q4 24
-26.3%
-758.8%
Q3 24
-30.4%
2848.7%
Q2 24
-54.4%
-2056.3%
Q1 24
-54.2%
-4807.7%
Capex Intensity
CTSO
CTSO
VAL
VAL
Q4 25
1.2%
2044.2%
Q3 25
0.2%
1246.4%
Q2 25
0.4%
9600.0%
Q1 25
0.0%
Q4 24
0.8%
-6570.6%
Q3 24
1.8%
2100.0%
Q2 24
0.2%
2295.8%
Q1 24
0.5%
5819.2%
Cash Conversion
CTSO
CTSO
VAL
VAL
Q4 25
0.10×
Q3 25
1.05×
Q2 25
-0.78×
1.04×
Q1 25
Q4 24
0.93×
Q3 24
2.99×
Q2 24
0.08×
Q1 24
1.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTSO
CTSO

Direct$5.1M55%
Distributors And Strategic Partners$4.2M45%

VAL
VAL

Segment breakdown not available.

Related Comparisons